DAO and Hyperoxaluria: Recent convergent validation across multi-species models (Drosophila, murine, and HK-2 cells) revealed that IL-6/JAK/STAT3 pathway activation epigenetically suppresses D-amino acid oxidase (DAO) transcription via DNA methylation modifications, thereby attenuating endogenous oxalate biosynthesis and mitigating hyperoxaluria risks.